These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34791159)

  • 1. Strengthening cardiovascular trials across Australia and New Zealand-the Alliance for Cardiovascular Trials (ANZACT) Network.
    Reid CM; Patel A; Nicholls SJ; Briffa T
    Eur Heart J; 2022 May; 43(17):1612-1614. PubMed ID: 34791159
    [No Abstract]   [Full Text] [Related]  

  • 2. Global Rounds: Cardiovascular Care in Australia and New Zealand.
    Zaman S; Edwards NC; Chew DP
    Circulation; 2024 Apr; 149(18):1402-1404. PubMed ID: 38683899
    [No Abstract]   [Full Text] [Related]  

  • 3. The Use of Telehealth to Reduce Inequalities in Cardiovascular Outcomes in Australia and New Zealand: A Critical Review.
    Wade V; Stocks N
    Heart Lung Circ; 2017 Apr; 26(4):331-337. PubMed ID: 27993487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular research in Australia and New Zealand: origins, current status, pre-eminent research groups, funding.
    MacDonald I
    Eur Heart J; 2009 May; 30(10):1159-61. PubMed ID: 19455722
    [No Abstract]   [Full Text] [Related]  

  • 5. Interventional practice in Australia and New Zealand: current trends.
    Juneja MS; Walters DL
    Indian Heart J; 2007; 59(2 Suppl B):B20-4. PubMed ID: 19153432
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular mortality in New Zealand and Australia 1968-1983: how can the diverging trends be explained?
    Beaglehole R; Bonita R; Jackson R; Stewart A
    N Z Med J; 1986 Jan; 99(794):1-3. PubMed ID: 3456096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand.
    LeLorier J; Rawson NS
    Can J Cardiol; 2007 Jul; 23(9):711-8. PubMed ID: 17622393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic care and risk factor management in cardiovascular disease.
    Zeitz CJ; Anderson CS; Tideman PA
    Heart Lung Circ; 2012 Oct; 21(10):623-5. PubMed ID: 22902383
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.
    Stewart RA; North FM; Sharples KJ; Simes RJ; Tonkin AM; White HD;
    N Z Med J; 2008 Feb; 121(1269):11-23. PubMed ID: 18278078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease.
    Brown A; Kritharides L
    Heart Lung Circ; 2010; 19(5-6):263. PubMed ID: 20363188
    [No Abstract]   [Full Text] [Related]  

  • 11. Equitable access to regional cardiovascular services.
    Jeremy R
    Heart Lung Circ; 2010 Jan; 19(1):1. PubMed ID: 20129112
    [No Abstract]   [Full Text] [Related]  

  • 12. Future directions in cardiovascular disease risk prediction.
    Doust JA; Bonner C; Bell KJL
    Aust J Gen Pract; 2020 Aug; 49(8):488-494. PubMed ID: 32738856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of clinical practice guidelines for the nursing care of people undergoing percutaneous coronary interventions: An Australian & New Zealand collaboration.
    Rolley JX; Salamonson Y; Dennison CR; Davidson PM
    Aust Crit Care; 2010 Nov; 23(4):177-87. PubMed ID: 20413321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations arising from the inaugural CSANZ Conference on Indigenous Cardiovascular Health.
    Kritharides L; Brown A; Brieger D; Ridell T; Zeitz C; Jeremy R; Tonkin A; Walsh W; White H;
    Heart Lung Circ; 2010; 19(5-6):269-72. PubMed ID: 20378405
    [No Abstract]   [Full Text] [Related]  

  • 15. Walking an Indigenous Pathway: Bridging the Gap in Cardiovascular Health.
    Rolleston A; Brown A
    Heart Lung Circ; 2019 Jun; 28(6):823-824. PubMed ID: 31076126
    [No Abstract]   [Full Text] [Related]  

  • 16. An evaluation of the telehealth facilitation of diabetes and cardiovascular care in remote Australian Indigenous communities: - protocol for the telehealth eye and associated medical services network [TEAMSnet] project, a pre-post study design.
    Brazionis L; Jenkins A; Keech A; Ryan C; Bursell SE;
    BMC Health Serv Res; 2017 Jan; 17(1):13. PubMed ID: 28056974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abstracts of the Cardiac Society of Australia and New Zealand annual meeting and the International Society for Heart Research annual meeting, 5-8 August 2005, Perth, Australia.
    Heart Lung Circ; 2005; 14 Suppl 1():S1-180. PubMed ID: 16498723
    [No Abstract]   [Full Text] [Related]  

  • 18. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
    Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
    Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement.
    Zaman S; MacIsaac AI; Jennings GL; Schlaich MP; Inglis SC; Arnold R; Kumar S; Thomas L; Wahi S; Lo S; Naismith C; Duffy SJ; Nicholls SJ; Newcomb A; Almeida AA; Wong S; Lund M; Chew DP; Kritharides L; Chow CK; Bhindi R
    Med J Aust; 2020 Aug; 213(4):182-187. PubMed ID: 32734645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cardiac Society Inaugural Cardiovascular Health Conference: conference findings and ways forward.
    Brown A; Tonkin A; White H; Riddell T; Brieger D; Walsh W; Zeitz C; Jeremy R; Kritharides L
    Heart Lung Circ; 2010; 19(5-6):264-8. PubMed ID: 20381422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.